FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair
ABOUT

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Welcome to the new SWOG: The latest "fresh" face on the SWOG leadership team

Aug 22, 2014 - Carol Moinpour, co-chair of SWOG's Symptom Control & Quality of Life Committee, has let me know she plans to step down from that role at the end of the year. She has led the Committee with James Wade since its inception in 2008, during which time its work has included three important clinical trials of treatments to relieve aromatase-inhibitor-induced joint pain in breast cancer patients. We thank her for her exemplary service.

In my discussions with Frank Meyskens, Dawn Hershman, and other NCORP senior leadership, we identified Michael Fisch as an outstanding candidate to succeed Dr. Moinpour in this role. I am happy to announce he has accepted my offer to take this position.

Chair of the Department of General Oncology at MD Anderson, Dr. Fisch is not technically new to SWOG leadership. He has headed our Social Media Working Group for over a year, and he has been largely responsible for driving increased SWOG member participation over a range of social media -- especially Twitter. With that working group, he has also explored virtual tumor boards and telementoring models for engaging our physicians at a distance, has intensified our collaboration with patient advocates and advocacy organizations heavily engaged in social media, and has put together guidelines in sane and effective use of social media by SWOG members and staff.

He brings an equally creative and entrepreneurial outlook to his newest SWOG role. In our correspondence, he has already suggested a number of great ideas regarding the interface of cancer care delivery research and symptom control/survivorship. As an inveterate explorer of new technologies and tools, he sees symptom control and quality of life as two areas in which personal technology has distinct benefits to offer, and he has even spoken of some specific tech startups we might collaborate with in terms of our clinical trials.

We are lucky to have Dr. Fisch as Social Media Working Group Chair, and now as Symptom Control & Quality of Life Co-Chair. I have no doubt that under the guidance of Drs. Fisch and Wade, that Committee will continue to design and conduct critical clinical research that will ease patient suffering and improve patient quality of life -- like the rest of our Group.


P.S. Last week's Front Line included a call for members interested in serving as liaisons between our Adolescent and Young Adult Committee and our other research committees. Your response was highly gratifying, and I'm happy to report the spirit of volunteerism is alive and well within SWOG! Thank you.

 

 
     
SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified